Apellis Pharmaceuticals, Inc. ($APLS)
Filing Information
| Accession Number | 0001492422-26-000073 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 30, 2026 |
| Document Date | Jan 28, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
58,140
Total Value
$0.00
P&L
+inf% (+$1,000,589.40)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jan 28, 2026 | Grant/Award | 58,140 | $0.00 | $0.00 | 152,041 | Direct | โ | View Details |